Table 3

Adverse events
IM Olz, 10 mg (N=45) IM Placebo (N=45)
Item n (%) n (%) p valuea
TEAE 13 (28.9) 6 (13.3) .120
ADR 9 (20.0) 4 (8.9) .230
TEAE leading to discontinuation 0 (0.0) 0 (0.0) ———
Severe TEAE 0 (0.0) 0 (0.0) ———
Serious adverse event 0 (0.0) 0 (0.0) ———

Abbreviations: ADR= adverse drug reaction; IM Olz=intramuscular olanzapine; N= number of patients in the full analysis set; n=number of patients with ≥1 event;TEAE=treatment-emergent adverse event.

ap value: Fisher's exact test.

Katagiri et al.

Katagiri et al. BMC Psychiatry 2013 13:20   doi:10.1186/1471-244X-13-20

Open Data